Happy Holidays and New year from the EMDB! Please be advised that the EMDB team will be operating at reduced capacity between December 15th - January 12th. With this in mind we would ask that you be prepared for longer reply times through both our helpdesk system and the OneDep deposition system. well done on a productive 2025, wishing you all the best and we will see you in 2026!

EMD-31792

Single-particle
3.3 Å
EMD-31792
3D View Gallery
Deposition: 22/08/2021
Map released: 06/10/2021
Last modified: 09/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-31792
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 7v87 summary report (pdf.gz) Map and 7v87 FULL report (pdf.gz)
EMICSS annotations (xml)

Local refinement of SARS-CoV-2 S-Kappa variant (B.1.617.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain

EMD-31792

Single-particle
3.3 Å
EMD-31792
3D View Gallery
Deposition: 22/08/2021
Map released: 06/10/2021
Last modified: 09/10/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Sample: SARS-CoV-2 spike glycoprotein complex with Angiotensin-converting enzyme 2 (ACE2) ectodomain
Fitted models: 7v87

Deposition Authors: Yang TJ , Yu PY

Local refinement of SARS-CoV-2 S-Kappa variant (B.1.617.1) RBD and Angiotensin-converting enzyme 2 (ACE2) ectodomain
Yang TJ , Yu PY , Chang YC , Hsu STD
To Be Published